Clinical Trials in Chicago

Showing 3961-3980 of 9,860 trials

Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device

NCT05368623

Diabetes affects over 37 million Americans and over 530 million people globally. Each diabetic patient needs at least one retinal exam per year starting immediately at the time of diagnosis if they have Type II diabetes (and starting at 5th year after disease onset if they have Type I diabetes). However, majority of diabetic patients do not get their eye exam due to multiple prohibitive factors such as cost, transportation, difficulty of taking time off from work, and inconvenience, amongst others. As a result, diabetes is the most common cause of visual impairment and blindness in working age adults in the United States and globally. Early detection via effective screening can prevent diabetes-related blindness. However, there are multiple barriers to screening. This prompted the development of RETINA-AI Galaxy™ v2.0, an automated Software as a Medical Device that screens for diabetic retinopathy in the primary care setting. This observational study was designed to validate the safety and efficacy of the RETINA-AI Galaxy™ Software-as-a-Medical-Device.

DiabetesDiabetic RetinopathyDiabetic Macular Edema+1 more

RETINA-AI Health, Inc.1,100 participantsStarted Nov 2022

Los Angeles, California, United States • Chicago, Illinois, United States • Houston, Texas, United States

COMPLETED2.2 miles

FoxBioNet: ECV (Extracellular Vesicle) 004

NCT04603326

The goal of this study is to identify reliable markers of LRRK2 activity in human CSF.

Parkinson Disease

Michael J. Fox Foundation for Parkinson's Research140 participantsStarted May 2021

Chicago, Illinois, United States • New York, New York, United States • Portland, Oregon, United States +1 more locations

Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device

FoxBioNet: ECV (Extracellular Vesicle) 004

Find Trials by Condition in Chicago

Advanced Multimodal Wireless Vital Signs Monitoring for Patients With Asthma and Anaphylaxis

Wearable Skin Sensors to Assess Nocturnal Scratch Behavior

Kick Out Parkinson's Disease- Karate Intervention

Intermittent Pneumatic Compression Device for Vein Dilation in Kidney Disease Patients to Enable AVF Creation (FACT)

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease

Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants

Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer

Alio WEAR Study: Long-term Wear of the Alio Platform

In-Stent Restenosis Post-Approval Study

Study of the CAT RX Aspiration Catheter When Used in Patients With Large Occlusive Thrombus in Coronary Arteries

VasQ External Support for Arteriovenous Fistula

Identifying and Facilitating Ventricular Recovery on Mechanical Support

Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis

A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML

A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors

Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery

Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis